Barclays PLC Taro Pharmaceutical Industries LTD Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$40.97 - $43.33 $224,433 - $237,361
-5,478 Reduced 37.64%
9,075 $385,000
Q4 2023

Feb 15, 2024
BUY
$32.77 - $42.31 $318,884 - $411,718
9,731 Added 201.8%
14,553 $608,000
Q3 2023

Nov 07, 2023
SELL
$35.46 - $40.13 $6,382 - $7,223
-180 Reduced 3.6%
4,822 $183,000
Q2 2023

Aug 03, 2023
BUY
$24.24 - $40.97 $121,248 - $204,931
5,002 New
5,002 $190,000
Q4 2021

Feb 14, 2022
SELL
$47.6 - $65.0 $4,950 - $6,760
-104 Reduced 98.11%
2 $0
Q3 2021

Nov 09, 2021
SELL
$62.34 - $73.38 $12,093 - $14,235
-194 Reduced 64.67%
106 $6,000
Q2 2021

Aug 13, 2021
SELL
$70.26 - $76.64 $161,598 - $176,272
-2,300 Reduced 88.46%
300 $22,000
Q1 2021

May 13, 2021
SELL
$70.48 - $79.95 $599,080 - $679,575
-8,500 Reduced 76.58%
2,600 $192,000
Q4 2020

Feb 11, 2021
BUY
$54.4 - $73.42 $315,520 - $425,836
5,800 Added 109.43%
11,100 $815,000
Q3 2020

Nov 12, 2020
SELL
$54.41 - $68.2 $152,348 - $190,960
-2,800 Reduced 34.57%
5,300 $291,000
Q2 2020

Aug 12, 2020
BUY
$61.66 - $70.16 $499,446 - $568,296
8,100 New
8,100 $539,000
Q4 2019

Feb 10, 2020
SELL
$74.18 - $97.92 $276,839 - $365,437
-3,732 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$75.36 - $86.57 $4,973 - $5,713
66 Added 1.8%
3,732 $282,000
Q2 2019

Aug 14, 2019
BUY
$83.92 - $108.88 $170,525 - $221,244
2,032 Added 124.36%
3,666 $313,000
Q1 2019

May 15, 2019
BUY
$85.97 - $108.09 $37,310 - $46,911
434 Added 36.17%
1,634 $176,000
Q4 2018

Feb 14, 2019
SELL
$78.25 - $107.92 $824,207 - $1.14 Million
-10,533 Reduced 89.77%
1,200 $102,000
Q3 2018

Nov 14, 2018
BUY
$97.82 - $116.09 $394,508 - $468,190
4,033 Added 52.38%
11,733 $1.15 Million
Q2 2018

Aug 14, 2018
SELL
$97.62 - $120.59 $429,625 - $530,716
-4,401 Reduced 36.37%
7,700 $891,000
Q1 2018

May 15, 2018
BUY
$95.91 - $107.26 $869,232 - $972,097
9,063 Added 298.32%
12,101 $1.19 Million
Q4 2017

Feb 14, 2018
SELL
$104.5 - $126.38 $2.1 Million - $2.54 Million
-20,134 Reduced 86.89%
3,038 $318,000
Q3 2017

Nov 14, 2017
BUY
$97.26 - $116.2 $2.25 Million - $2.69 Million
23,172
23,172 $2.61 Million

Others Institutions Holding TARO

# of Institutions
9
Shares Held
17K
Call Options Held
0
Put Options Held
0
View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

TARO Quotes by TradingView
  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email